Retatrutide, a innovative dual-action peptide, is steadily gaining recognition in the world of weight reduction. This distinctive medication integrates the functions of GLP-1 receptor agonists and GIP receptor agonists , offering a potentially more holistic approach to addressing obesity. Early r